News & Observer readers comments on NC's business ranking, speeding in a Raleigh area, a gun bill, flooding, Thom Tillis, ...

Ian Clark, then-CEO of Genentech, sits between statues of Genentech founders Herb Boyer and Bob Swanson at Genentech's campus in South San Francisco.

Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Genentech's position, that $89 a share "substantially undervalues" the company, is similar to what ImClone Systems, another biotech leader, told drugmaker Bristol-Myers Squibb last week.

Genentech's market cap of about $30 billion is now bigger than that of some Big Pharma players like Schering-Plough. Even more remarkable, last year Genentech became the top U.S. seller of branded ...

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, ...

Genentech looks for people who are wired like Ellen Filvaroff, a senior scientist in molecular oncology. Her walls are decorated with pictures of her patents and her toddler--side by side.

Genentech Inc. said Thursday that it has completed the $919 million acquisition of Tanox Inc., its partner in the development of the asthma drug Xolair, ...

Genentech will close its cancer immunology research department, and unit head and renowned cell biologist Ira Mellman, who has been with the company for 17 years, will depart in the coming months.

For the Bay Area, the impact of Genentech's sale goes far beyond a change of nameplates on a big local company. Genentech was the region's home-grown luminary, with a leading role in the ...